NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy

Overview of attention for article published in Radiation Oncology, September 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 8 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 17,186 followers.

RT @_ShankarSiva: @DrMLChua @SimonLo21054188 @DrStish @alison_tree @sueyom @Mat_Guc @KristinRedmond2 @DrewMoghanaki @PercyLeeMD @TimothyKru…

13 Oct 2021

Reply Repost Favourite

@DrMLChua @SimonLo21054188 @DrStish @alison_tree @sueyom @Mat_Guc @KristinRedmond2 @DrewMoghanaki @PercyLeeMD @TimothyKruserMD @PeterMacRadOnc @EvanThomas84 @PBlanchardMD Hi @alison_tree - yes we have seen marginal failures @PeterMacCC. Predominantly in #b

13 Oct 2021

Reply Repost Favourite

@AlisonRoth14 is presenting our first fully virtual journal club article tomorrow morning. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy by @HardcastleNick et al.

22 Mar 2020

Reply Repost Favourite

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy. https://t.co/XnTXNCZQIP

16 Feb 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.